Conn’s (NASDAQ:CONN – Get Rating) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Friday.
Conn’s Trading Up 4.4 %
NASDAQ CONN opened at $4.48 on Friday. Conn’s has a 12 month low of $3.90 and a 12 month high of $14.27. The firm has a market capitalization of $108.15 million, a P/E ratio of -1.80 and a beta of 2.53. The business has a fifty day simple moving average of $5.34 and a 200 day simple moving average of $7.50. The company has a current ratio of 3.74, a quick ratio of 2.65 and a debt-to-equity ratio of 1.27.
Conn’s (NASDAQ:CONN – Get Rating) last announced its earnings results on Wednesday, March 29th. The specialty retailer reported ($1.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by ($0.77). Conn’s had a negative net margin of 4.42% and a negative return on equity of 8.92%. The business had revenue of $334.90 million for the quarter, compared to analysts’ expectations of $331.22 million. During the same period in the prior year, the business earned $0.33 earnings per share. The company’s revenue for the quarter was down 16.8% compared to the same quarter last year. On average, analysts predict that Conn’s will post -3.98 EPS for the current fiscal year.
Institutional Inflows and Outflows
About Conn’s
Conn’s, Inc is a holding company, which engages in the retail and provision of home goods and related services. Its products include furniture, appliances, and consumer electronics. It operates through the Retail and Credit segments. The Retail segment sells home appliances to the retail market, and owns and operates retail stores that offer furniture, home appliances, consumer electronics, and home office accessories.
Featured Stories
- Get a free copy of the StockNews.com research report on Conn’s (CONN)
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Conn's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conn's and related companies with MarketBeat.com's FREE daily email newsletter.